Shockwave therapy, formally known as low-intensity extracorporeal shockwave therapy (Li-ESWT), is a non-invasive treatment that uses controlled acoustic waves to stimulate biological processes involved in vascular repair. For men with vasculogenic erectile dysfunction, the goal is to improve penile blood flow and support healthier erectile function.
Shockwave therapy is generally best suited to men whose erectile dysfunction has a significant vascular component. This may include men with mild to moderate vasculogenic ED, a gradual age-related decline in erection quality, vascular risk factors, or a partial or declining response to oral ED medications.
A comprehensive evaluation is important because hormonal deficiencies, medication effects, neurologic conditions, prior pelvic surgery, psychological factors, and other conditions may require additional or alternative treatment.
Numerous randomized controlled trials, systematic reviews, and meta-analyses have reported improvements in erectile function among appropriately selected men, with the strongest evidence in mild to moderate vasculogenic ED. Studies have demonstrated improvements in validated erectile-function scores, penile blood flow, and responsiveness to ED medications.
Results vary based on the underlying cause and severity of ED, patient selection, treatment protocol, and technology used. Shockwave therapy is not effective for every patient.
Potentially. Clinical studies have found that some men who previously had an inadequate response to PDE5 inhibitors became responsive following shockwave therapy. Improving penile vascular function may enhance the effectiveness of medications that previously provided limited benefit.
However, a poor response to oral ED medication can have several causes, so evaluation is important before determining whether shockwave therapy is appropriate.
Shockwave therapy is non-invasive and generally well tolerated. A handheld device is applied externally to several areas of the penis to deliver controlled acoustic pulses, and most patients experience little to no discomfort. Treatment does not typically require anesthesia.
The duration of improvement varies among patients and depends on factors such as the underlying cause and severity of ED, age, cardiovascular and metabolic health, lifestyle, and progression of vascular disease.
Once a satisfactory response has been achieved, the need for future or maintenance treatment can be evaluated individually. Long-term erectile health also depends on addressing the underlying factors affecting vascular function.
Low-intensity shockwave therapy is non-invasive and has demonstrated a favorable safety profile in published clinical studies. It does not require surgery, injections, or anesthesia, and patients generally experience little to no downtime.
Appropriate patient selection and the use of suitable medical technology and treatment protocols remain important components of safe and effective treatment.
No. “Shockwave therapy” is used to describe different technologies, and not all devices deliver the same type of acoustic energy or have been evaluated using the same clinical protocols. Differences in energy delivery, penetration depth, treatment settings, and whether the technology is focused or radial can affect how treatment is administered and make results difficult to generalize across devices.
Performance Men’s Health utilizes both focused and radial shockwave technologies, selecting the device and treatment parameters based on the individual patient's condition and treatment objectives.
Shockwave therapy delivers low-intensity acoustic waves to the erectile tissues using a handheld device applied externally to the penis. Research suggests these acoustic waves may stimulate angiogenesis (the formation of new blood vessels), improve endothelial function and nitric oxide signaling, and support tissue remodeling. These changes may improve penile circulation and erectile function over time.
The strongest clinical evidence supports shockwave therapy for mild to moderate vasculogenic erectile dysfunction, particularly in men who retain some natural erectile function. Results may be less predictable when ED is primarily caused by significant nerve injury, severe structural or vascular disease, hormonal abnormalities, medication effects, or psychological factors.
For some men, yes. Some patients experience enough improvement in erectile function to reduce or discontinue sildenafil (Viagra®), tadalafil (Cialis®), or other ED medications. Others continue medication but experience firmer, more consistent erections or an improved response.
The goal is not necessarily to eliminate medication, but to optimize erectile function using the combination of treatments most appropriate for the individual.
Most patients begin with a series of six treatments performed approximately one to two times per week. Depending on the severity of ED, treatment goals, and clinical response, some patients may benefit from a six- to twelve-treatment protocol.
Because shockwave therapy works by stimulating gradual biological changes rather than producing an immediate pharmacologic effect, treatment is performed as a series rather than a single session.
No downtime is generally required. Patients can return to their usual daily activities immediately following treatment and can continue normal sexual activity without a required recovery period.
Shockwave therapy does not produce an immediate effect like an oral ED medication. Improvements typically develop gradually over several weeks as the biological processes associated with vascular repair and remodeling progress. Some patients notice changes during their treatment series, while others experience continued improvement after completing treatment.
No. Low-intensity shockwave therapy is not currently FDA-approved specifically for the treatment of erectile dysfunction and is considered an investigational treatment for ED. However, it has been evaluated in numerous clinical studies and is used by physicians as an off-label treatment for appropriately selected patients with vasculogenic erectile dysfunction.
Schedule a consultation with the Performance Men's Health team.